Search Results 191-200 of 17124 for pharmacogenetics
The goal of this study is to evaluate the integration of cancer genetic testing into a community cancer clinical practice aimed toward patients of various ...
Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more ...
About this study. The objectives of this study are to perform molecular and/or biochemical testing in individuals with suspected hereditary disorders, ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Review the focus areas, mentors and publications of current and former trainees in the Clinical Pharmacology Training Program at Mayo Clinic.
About this study. Can the genetic makeup of an individual who does not yet have cancer provide an indication of the risk of future cancer?
The purpose of this study approach aims to identify exomic alterations that contribute to the development of kidney disease. Participation eligibility.
Dr. Springer's Translational Cell Biology of Parkinson's Disease Lab at Mayo Clinic studies PINK1/PRKN (Parkin)-directed mitochondrial quality control.
Learn how genetic testing can help customize your cancer treatment plan. Precision medicine is improving breast cancer diagnosis, treatment and prevention.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!